Research programme: galectin-3 inhibitors - Galectin Sciences

Drug Profile

Research programme: galectin-3 inhibitors - Galectin Sciences

Alternative Names: Galectin 3 inhibitors - Galectin Sciences

Latest Information Update: 30 Jan 2014

Price : $50

At a glance

  • Originator Galectin Sciences
  • Class Organic chemicals; Small molecules
  • Mechanism of Action Galectin 3 inhibitors; Galectin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

  • New Molecular Entity Yes

Highest Development Phases

  • Research Cancer; Fibrosis

Most Recent Events

  • 27 Jan 2014 Early research in Fibrosis in USA (PO)
  • 27 Jan 2014 Early research in Cancer in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top